image
Healthcare - Biotechnology - NASDAQ - US
$ 0.8899
-8.27 %
$ 38.8 M
Market Cap
-0.56
P/E
BALANCE SHEET
51.6 M ASSETS
11.96%
24.8 M LIABILITIES
-11.23%
26.8 M EQUITY
47.80%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Tempest Therapeutics, Inc.
image
Current Assets 40.4 M
Cash & Short-Term Investments 39.2 M
Receivables 0
Other Current Assets 1.13 M
Non-Current Assets 11.2 M
Long-Term Investments 0
PP&E 10.8 M
Other Non-Current Assets 448 K
Current Liabilities 9.41 M
Accounts Payable 845 K
Short-Term Debt 6.19 M
Other Current Liabilities 2.38 M
Non-Current Liabilities 15.4 M
Long-Term Debt 15.4 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 39.2 31.2 51.8 18.8 63.5 73.3 17.6 43.9 43.4 6.4 18.1 14.8
Short Term Investments 0 0 0 0 0 4.4 51.5 70.5 83.4 53.8 26.3 16.6
Receivables 0 0 0 0.3 1.3 2.3 1.0 0 0 0 0 0
Inventory 0 0 1.6 0.7 0 0 1 0 0 0 0 0
Other Current Assets 1.1 1.4 17.1 0.7 8.7 3.4 (48.5) 2.1 3.0 1.6 0.7 0.6
Total Current Assets 40.4 33.0 69.0 19.8 71.1 83.4 19.7 116.4 129.9 61.9 45.1 32.0
PP&E 10.8 12.7 4.2 3.0 3.3 0 3.1 5.6 8.3 3.4 0.9 0.8
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0.4 0.1 0.5 0.4 0 1.5 0
Other Long Term Assets 0.4 0.4 0.1 51 K 0.5 0.2 (3.2) 23 K 0 0.3 88 K 93 K
Other Assets 0 0 0 0 1 0 0 0 1 0 0 0
Total Assets 51.6 46.1 73.2 22.9 75.0 84.1 19.8 122.5 138.6 65.6 47.5 32.8
LIABILITIES
Accounts Payable 0.8 1.1 1.0 1.1 1.5 2.0 1.3 2.2 3.4 2.5 1.7 0.9
Short Term Debt 6.2 2.8 2.9 0.7 2.0 0.2 0.2 0 0 0 0 0
Other Current Liabilities 2.4 3.3 16.2 1.4 9.0 7.6 2.3 11.0 7.9 7.7 4.1 1.2
Total Current Liabilities 9.4 7.3 20.0 3.2 12.5 9.8 4.1 13.2 11.2 10.2 5.8 2.1
Long Term Debt 15.4 20.7 17.1 1.7 2.3 0.4 0.6 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 86.7 0.2 0.8 0.1 1.1 0.5 73 K 70 K 7 K
Total Liabilities 24.8 28.0 37.1 91.7 15.1 11.0 4.8 14.3 11.8 10.2 5.8 2.1
EQUITY
Common Stock 22 K 11 K 7 K 15 K 18 K 13 K 36 K 36 K 27 K 24 K 18 K 14 K
Retained Earnings (165.3) (135.8) (100.1) (71.8) (208.7) (164.1) (136.9) (250.2) (167.9) (94.7) (45.2) (16.1)
Other Accumulative Comprehensive Income/Loss 0 0 (73.2) 0.5 0.2 0.1 19 K 60 K (0.2) (1.1) (0.7) 6 K
Total Equity 26.8 18.1 36.1 (68.1) 59.9 73.1 15.0 108.2 126.8 55.3 41.7 30.7
Total Liabilities and Equity 51.6 46.1 73.2 22.9 75.0 84.1 19.8 122.5 138.6 65.6 47.5 32.8
SHARES OUTSTANDING
Common Shares Outstanding 15.4 11.5 3.8 31.2 K 0.9 0.1 1.17 K 0.1 0.1 0.1 0.1 0